Trials / Sponsors / Larimar Therapeutics, Inc.
Larimar Therapeutics, Inc.
Industry · 7 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Study to Assess Nomlabofusp in Adolescents and Children With Friedreich's Ataxia Friedreich Ataxia | Phase 1 | 2024-12-06 |
| Recruiting | An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia Friedreich Ataxia | Phase 2 | 2024-01-25 |
| Completed | A Double-Blind, Placebo-Controlled, Dose Exploration Study of CTI-1601 in Adult Subjects With Friedreich's Ata Friedreich Ataxia | Phase 2 | 2022-09-21 |
| Completed | Determine Range of Tissue Frataxin Concentrations and Other Potential Biomarkers Friedreich Ataxia, Healthy Volunteers | — | 2021-08-04 |
| Completed | Multiple Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia Friedreich Ataxia | Phase 1 | 2020-07-31 |
| Completed | A Study to Assess Variation in Potential Biomarkers in Friedreich Ataxia Friedreich Ataxia | — | 2020-01-14 |
| Completed | Single Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia Friedreich Ataxia | Phase 1 | 2019-12-11 |